|
⚲
|
| Keyboard |
| Vor Biopharma Inc | |
|---|---|
| Ticker | VOR |
| CIK # | 0001817229 |
| CUSIP | 929033108 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 215 First Street Suite 430, Cambridge, MA 02142 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Vor Biopharma Inc | 2020-07-10 | 110.1 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001817229] | 10-K | |
| [0001817229] | 10-Q | |
| [0001817229] | 3 | |
| [0001817229] | 4 | |
| [0001817229] | 8-K | |
| [0001817229] | D | |
| [0001817229] | SC 13D | |
| [0001817229] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Levin Andrew David
Stock Option (Right to Buy) · derivative
|
2025-12-18 | Grant | 3,000 | $0.00 | |
|
Joustra Wouter
Stock Option (Right to Buy) · derivative
|
2025-12-18 | Grant | 3,000 | $0.00 | |
|
Shah Rajeev M +3
Stock Option (Right to Buy) · derivative
|
2025-12-18 | Grant | 3,000 | $0.00 | |
|
Shah Rajeev M +3
Common Stock
|
2025-12-18 | Grant | 4,625,346 | $10.81 | 49,999,990 |
|
Kress Jean-Paul
Employee Stock Option (right to buy) · derivative
|
2025-12-05 | Grant | 4,164,831 | $0.00 | |
|
Mahatme Sandesh
Common Stock
|
2025-12-05 | Disposed to issuer | 694,137 | $0.00 | |
|
Kress Jean-Paul
Employee Stock Option (right to buy) · derivative
|
2025-12-05 | Disposed to issuer | 4,164,831 | $0.00 | |
|
Mahatme Sandesh
Employee Stock Option (right to buy) · derivative
|
2025-12-05 | Grant | 1,388,274 | $0.00 | |
|
Zuraw Qing Che
Employee Stock Option (right to buy) · derivative
|
2025-12-05 | Disposed to issuer | 218,652 | $0.00 | |
|
Zuraw Qing Che
Employee Stock Option (right to buy) · derivative
|
2025-12-05 | Grant | 218,652 | $0.00 | |
|
Shah Rajeev M +3
Common Stock
|
2025-10-30 | Sell | 24,579 | $25.12 | 617,424 |
|
Shah Rajeev M +3
Common Stock
|
2025-10-29 | Sell | 251,518 | $25.22 | 6,343,284 |
|
Shah Rajeev M +3
Common Stock
|
2025-10-28 | Sell | 36,483 | $28.18 | 1,028,091 |
|
Shah Rajeev M +3
Common Stock
|
2025-10-28 | Sell | 87,828 | $27.10 | 2,380,139 |
|
Shah Rajeev M +3
Common Stock
|
2025-10-27 | Sell | 90,941 | $28.12 | 2,557,261 |
|
Shah Rajeev M +3
Common Stock
|
2025-10-24 | Sell | 53,345 | $28.01 | 1,494,193 |
|
Shah Rajeev M +3
Common Stock
|
2025-10-23 | Sell | 76,880 | $28.01 | 2,153,409 |
|
Shah Rajeev M +4
Common Stock
|
2025-10-21 | Sell | 25,027 | $28.11 | 703,509 |
|
Reprogrammed Interchange LLC +1
Common Stock
|
2025-10-21 | Sell | 200 | $30.08 | 6,016 |
|
Reprogrammed Interchange LLC +1
Common Stock
|
2025-10-20 | Sell | 11,616 | $30.05 | 349,061 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 80 | 40,624,899 |
| 2025-12-31 | 56 | 27,023,288 |
| 2025-09-30 | 41 | 10,201,924 |
| 2025-06-30 | 41 | 61,120,658 |
| 2025-03-31 | 47 | 60,145,955 |
| 2024-12-31 | 53 | 60,969,660 |
| 2024-09-30 | 55 | 47,855,210 |
| 2024-06-30 | 72 | 54,534,020 |
| 2024-03-31 | 70 | 59,220,987 |
| 2023-12-31 | 61 | 59,802,960 |
| 2023-09-30 | 60 | 60,222,482 |
| 2023-06-30 | 72 | 60,812,277 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Y-Intercept Hong Kong Ltd | [2026-06-30] | SOLE | 17,238 | 17,238 | Prev | Page 1 | Next |